All civil unrest articles
-
AnalysisWhy French riots mean that global SRCC coverage may get more expensive
New research from DBRS Morningstar finds that the riots in France could have severe impacts on the global strike, riot, and civil commotion insurance (SRCC) market. Here’s what risk managers need to know
-
AnalysisInsured losses from strikes, riots and civil commotion now comparable to major natural disasters
Risk managers face reduced political violence (PV) insurance and strikes, riots and civil commotion (SRCC) cover, thanks to global outbreaks of violence
-
NewsAGCS outlines five risk drivers of political violence
Civil unrest risks has risen substantially, causing billions of dollars in property damage and business interruption
-
NewsRussia-Ukraine conflict: At a crossroads
Both sides appear to be gearing up for a long, attritional war, with consequences on both sides
-
News2023 will bring heightened levels of unrest
Further geopolitical disruption expected as crisis management teams remain in ‘perma-crisis’ mode
-
NewsBlack Sea grain deal will ease supply bottlenecks
UN Secretary General Antonio Guterres has hailed the accord a “beacon of hope”
-
NewsSingapore, New Zealand warn against travel to Sri Lanka
A curfew has been imposed in Colombo after further violent protests and troops are patrolling the streets
-
NewsCost of living crisis inflames civil unrest risks
Sri Lanka and Kazakhstan have already experienced destabilising unrest this year
-
NewsHong Kong in bid to strengthen international risk management role
The region’s chief executive Carrie Lam outlined plans to strengthen the SAR’s position as a centre for risk and insurance
-
NewsBCPs must explicitly address civil unrest
Civil unrest is now the main political risk exposure for companies, with COVID-19 likely to fuel further disturbances
-
NewsFive liability trends for a COVID age
Rising litigation; more costly recalls; civil unrest and the increased potential for indoor air quality claims are just some of the liability trends exacerbated by COVID-19